Effect of a new physiotherapy concept on bone mineral density, muscle force and gross motor function in children with bilateral cerebral palsy.

OBJECTIVE: The purpose of this study was to determine the effect of a new physiotherapy concept on bone density, muscle force and motor function in bilateral spastic cerebral palsy children. METHODS: In a retrospective data analysis 78 children were analysed. The concept included whole body vibration, physiotherapy, resistance training and treadmill training. The concept is structured in two in-patient stays and two periods of three months home-based vibration training. Outcome measures were dual-energy x-ray absorption (DXA), Leonardo Tilt Table and a modified Gross Motor Function Measure before and after six months of training. RESULTS: Percent changes were highly significant for bone mineral density, -content, muscle mass and significant for angle of verticalisation, muscle force and modified Gross Motor Function Measure after six months training. CONCLUSIONS: The new physiotherapy concept had a significant effect on bone mineral density, muscle force and gross motor function in bilateral spastic cerebral palsy children. This implicates an amelioration in all International Classification of Functioning, Disability and Health levels. The study serves as a basis for future research on evidence based paediatric physiotherapy taking into account developmental implications.

Mechanographic analyses in pediatrics: allometric scaling of 'peak jump force' and its relationship to 'maximal isometric grip force' in childhood and adolescence.

BACKGROUND: Kinetic analyses of the neuromuscular system have become an important part in the diagnostics of metabolic bone disorders in pediatrics because of the relevance of the 'Functional Muscle-Bone Unit'. Because muscle function is associated with muscle metabolism, it is suggested that the association of maximal forces with anthropometric variables (e. g., body weight) is characterized by allometric scaling. The present manuscript aims to describe the scaling exponent for the association of maximal forces of mechanography and dynamometry to body weight and exemplarily applies the prediction of 'Peak Jump Force' (PJF) by 'Maximal Isometric Grip Force' (MIGF) for the characterization of the unconditioned neuromuscular system in subjects with congenital heart disease (CHD). SUBJECTS: MIGF was measured in a reference population of 135 school boys and 177 school girls who were not randomized individuals of a German primary and high-school. In addition, data of the neuromuscular system were analyzed in 29 individuals with CHD. METHODS: Participants performed counter-movement jumping on a force plate to measure PJF and v (max). MIGF was determined by dynamometric measurement. RESULTS: PJF scaled (body mass) (0.97) in girls and (body mass) (1.05) in boys. PJF was not different from the scaling exponent=1 in both genders. After having taken the logarithm, MIGF predicted PJF with R (2)(adjusted)=0.774 in boys, R (2)(adjusted)=0.720 in girls (p<0.001 each) and R (2)(adjusted)=0.209 (p=0.007) in patients with CHD. The mean of the predicted PJF was lower than the mean of the measured PJF in subjects with CHD (p<0.001). The difference between the predicted and the measured PJF (DeltaPJF) was associated with v (max) (R (2)(adjusted)=0.113, p=0.042). CONCLUSIONS: PJF scales body weight in an isometric way as recently describe for other vertebrates. MIGF is a good predictor of PJF in healthy children, but not in unconditioned individuals. DeltaPJF indicates conditioning of the individual and may be used to describe inter- and intramuscular coordination in children. HINTERGRUND: Mechanografische Analysen des neuromuskulären Systems haben mittlerweile auch einen diagnostischen Stellenwert in der Pädiatrie erlangt. Ziel der vorliegenden Untersuchung ist die kinetische Analyse des Counter-movement-Sprungs durch die Messung der Bodenreaktionskräfte in Hinblick auf seine allometrische Skalierung und im Vergleich zur Entwicklung der ,Maximalen isometrischen Griffstärke' (MIGF) bei Kindern und Jugendlichen. PROBANDEN: Die Studienpopulation umfasste 135 Schüler und 177 Schülerinnen, die nicht randomisiert wurden und Schüler einer deutschen Grundschule und eines deutschen Gymnasiums waren. Zudem wurden Daten von 29 Patienten mit kongenitalen Herzfehlern analysiert. METHODEN: Die Studienteilnehmer absolvierten Counter-movement-Sprünge auf einer Sprungplatte, sodass die maximale Sprungkraft (Peak Jump Force, PJF) und die maximale Geschwindigkeit des Massenschwerpunktes beim Absprung (v (max)) ermittelt werden konnten. MIGF wurde durch Messung mit einem Dynamometer bestimmt. ERGEBNISSE: PJF-skalierte (Körpermasse) (0,97) bei den Mädchen und (Körpermasse) (1,05) bei den Jungen. Der Skalierungsfaktor von PJF war bei Mädchen und Jungen nicht signifikant vom Faktor=1 verschieden. Nach Lograithmierung sagte die Variable MIGF den Parameter PJF in der Gruppe der Jungen mit R (2)(adjusted)=0,774, in der Gruppe der Mädchen mit R (2)(adjusted)=0,720 (jeweils p<0,001) und in der Gruppe der Herzkranken mit R (2)(adjusted)=0,209 (p=0,007) voraus. Der Mittelwert des vorhergesagten Wertes für PJF war niedriger als der Wert der gemessenen PJF in Patienten mit Herzerkrankung (p<0,001). Die Differenz zwischen vorhergesagter und gemessener PJF (DeltaPJF) stand statistisch mit v (max) (R (2)(adjusted)=0,113; p=0,042) in Zusammenhang. SCHLUSSFOLGERUNGEN: PJF skaliert isometrisch zur Körpermasse, wie es bereits für andere Vertebraten beschrieben wurde. MIGF ist ein guter Prädiktor für PJF bei gesunden Kindern und Jugendlichen, jedoch nicht bei Menschen mit einem unkonditionierten neuromuskulären System. DeltaPJF kann als Marker für die Konditionierung eines neuromuskulären Systems angesehen werden und beschreibt inter- und intramuskuläre Koordination.

The influence of auxology and long-term glycemic control on muscle function in children and adolescents with type 1 diabetes mellitus.

We intended to investigate in this pilot-study if long-term glycemic control stands in close relationship with muscle function in children and adolescents with type 1 diabetes mellitus (T1DM). Muscle function (MIGF, maximal isometric grip force; PJF, peak jump force; PJP, peak jump power) was investigated in 40 children and adolescents (males 20, females 20; age 13.5-/+2.5 yr) affected with T1DM. Muscular parameters were correlated with anthropometric parameters (age, height, weight) and with glycosylated hemoglobin (HbA1c) of the presence and the past. Standard deviation scores (SDSs) of weight and MIGF indicated significantly higher weight (mean 0.75-/+1.83 (SD)) and lower MIGF (mean -1.06-/+1.76 (SD)) in individuals with T1DM. When the study group was divided into two groups by the criteria that the actual HbA1c (HbA1c0) was lower (N=25) or higher (N=15) than 8.5%, the comparison showed significantly higher muscular parameters (PJF-SDS, PJP-SDS and MIGF-SDS) in individuals with higher HbA1c0. Multiple regression analyses demonstrated that body weight and height primarily predicted muscle force (MIGF, PJF) in T1DM. In conclusion, skeletal growth is an important determinant for the development of muscle function in children and adolescents with T1DM.

A cybernetic approach to osteoporosis in anorexia nervosa.

A group of 25 female individuals, who had been admitted to the University Hospital with the diagnosis of anorexia nervosa (AN) 3 to 10 years before, was seen for a follow-up visit in the hospital. These women got a psychiatric exploration to detect a present eating disorder. Moreover, parameters of the muskuloskeletal interaction were determined on the non-dominant forearm. Bone mineral content (BMC) of the radius was measured by pQCT and maximal grip force was evaluated by the use of a dynamometer. Eating disorders were present in 12 females. The mean of BMC standard deviation (SD) score was significantly reduced in comparison with reference values. Furthermore, the mean of BMC SD score was also significantly lower than the mean of grip force in SD score. These results gave the suggestion that the adaptation of bone mass to biomechanical forces is disturbed in AN. The linear regression analyses between the parameters grip force and BMC were compared between the study and the reference group. The comparison delivered a significantly lower constant in the regression equation of the study group. This result can be interpreted on the background of the mechanostat theory. The affection with an eating disorder decreases the set point in the feedback loop of bone modeling. The results offer for the first time the possibility to analyse osteoporosis in anorexic females under the paradigm of muskuloskeletal interaction.

Seasonality of growth response to GH therapy in prepubertal children with idiopathic growth hormone deficiency.

OBJECTIVE: Longitudinal growth of children exhibits seasonal variation. In both healthy children and in children with growth hormone (GH) deficiency (GHD) receiving GH therapy, growth rate is maximal during spring and summer. In the present study, we analyzed the growth response to GH therapy in children with GHD as a function of the season when therapy was started. SUBJECTS AND METHODS: Anthropometric measurements and biochemical analyses of GH secretion status and bone formation were longitudinally assessed in a cohort of 52 prepubertal children with GHD (14 girls, mean age 7.6 years) who were treated with a fixed dose of GH (0.025 mg/kg/day). RESULTS: Auxological assessments over the 2-year observation period revealed a significantly better growth response to GH therapy in children who started therapy between the spring and summer (group 1) compared with children who started in the autumn or winter (group 2). The difference was largest in the initial 3-month treatment period (35%; P<0.01). The initial better gain in height of group 1 was sustained during the study period. Baseline peak GH levels during stimulation tests and insuin-like growth factor-I levels did not differ between the two groups. However, group 1 had significantly higher bone resorption and formation markers, either at the start or shortly after initiation of GH treatment. This suggests that children with GHD have higher bone turnover during spring and early summer, irrespective of GH therapy. CONCLUSIONS: In summary, this study suggests that the season of GH initiation is a determinant of the initial growth response to GH replacement in prepubertal children with GHD.

The bone mass concept: problems in short stature.

Bone densitometry is currently one of the mainstays in the evaluation of systemic bone diseases in adults and is also increasingly used to assess primary or secondary bone disorders in children and adolescents. The purpose of carrying out densitometric studies in such circumstances is to measure the densitometric indicators of bone stability. Following procedures which were established for diagnosing adult osteoporosis, a decrease in densitometric surrogates of bone stability is usually interpreted as indicating increased fracture risk. The most basic densitometric parameter is bone mineral content (BMC), which can be measured with most densitometric techniques. BMC is either defined as the mass of mineral contained in an entire bone or as the mass of mineral per unit bone length. While mineral mass can be expected to be a good surrogate for bone stability, BMC is obviously a size-dependent parameter, since small bones weigh less than big bones. This is a drawback in paediatric use, since many children and adolescents who are examined by densitometry suffer from chronic disorders and are small-for-age. Short children will have a lower BMC than their healthy age-matched peers, even if their (smaller) bones are otherwise completely normal.

Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine.

OBJECTIVE: To examine bone development in children and adolescents who have uncomplicated idiopathic epilepsy and had received monotherapy with carbamazepine or valproic acid for at least 1 year. METHODS: Thirty-nine patients from 6 to 19 years of age (18 girls) were studied. Total bone mineral content (BMC) and trabecular volumetric bone mineral density were measured at the distal radius using peripheral quantitative computed tomography. Maximum isometric grip force was determined with a standard dynamometer. Alkaline phosphatase activity and deoxypyridinoline (a marker of bone resorption) were assessed in serum and urine, respectively. RESULTS: Trabecular volumetric bone mineral density was significantly decreased in the entire group (z score mean +/- standard deviation: -0.62 +/- 1.04) and in the subgroup using valproic acid (-0.75 +/- 1.18). In the carbamazepine subgroup, there was a similar but nonsignificant trend (-0.50 +/- 0.90). Total BMC and isometric maximum grip force were normal in the entire study population (0.10 +/- 1.22) and in the 2 subgroups. The relationship between BMC and grip force was similar between patients and healthy participants. Urinary levels of deoxypyridinoline were significantly elevated above normal in the whole study population (1.35 +/- 2.00) and in both the valproic acid and the carbamazepine subgroups. CONCLUSIONS: Bone turnover can be increased, but bone mass is adequate in children and adolescents who have uncomplicated idiopathic epilepsy and who receive monotherapy with carbamazepine or valproic acid.

A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency.

OBJECTIVE: To identify parameters which predict individual growth response to recombinant human GH (rhGH) therapy and to combine these parameters in a prediction model. DESIGN: Fifty-eight prepubertal patients with GH deficiency (17 females) participated in this prospective multicenter trial with 1 year of follow-up. METHODS: Auxological measurements, parameters of GH status and markers of bone metabolism were measured at baseline and at 1, 3 and 6 months after the start of rhGH treatment. Correlations with height velocity during the first 12 months of treatment (HV+12) were calculated. Prediction models were derived by multiple regression analysis. RESULTS: The model which best predicted HV+12 combined the following parameters: pretreatment bone age retardation as a fraction of chronological age, pretreatment serum levels of IGF-I, urinary levels of deoxypyridinoline (a marker of bone resorption) after 1 month of treatment and height velocity after 3 months of treatment. This model explained 89% of the variation in HV+12 with a standard deviation of the residuals of 0.93 cm/year. Defining successful rhGH therapy as a doubling of pretreatment height velocity, the model had a specificity of 90% and a sensitivity of 100% in predicting therapeutic success. CONCLUSIONS: This model is an accurate and practicable tool to predict growth response in GH-deficient children. It may help to optimize rhGH therapy by individual dose adjustment and contribute to improved overall outcomes.

Chemiluminescence immunometric assay for measuring osteocalcin in healthy children.

Osteocalcin (OC) was measured in serum samples from 92 children and adolescents (57 females, 35 males) by a two-site chemiluminescence immunometric assay (Nichols Institute Diagnostics, USA), which recognizes the 1-19 region of the whole molecule as well as the large N-terminal midregion fragment representing the main part of OC in serum. The highest OC levels are measured between the age of 10-15 years. The linear correlations between OC and alkaline phosphatase were 0.65 (p < .01) for total alkaline phosphatase (TAP) and 0.61 (p < 0.1) for bone alkaline phosphatase (BAP).

Urinary excretion of galactosyl-hydroxylysine is a marker of growth in children.

Galactosyl-hydroxylysine (Gal-Hyl) is the predominant product of the posttranslational glycosylation of skeletal collagen. Urinary Gal-Hyl excretion is regarded as a marker of bone resorption in adults, but little information is available on the validity of this parameter in pediatric age groups. Using 24-h urine samples from 88 healthy children and adolescents ages 4-18 yr, reference ranges were established for this age group, and values were compared with measurements in children with overt GH deficiency (n = 14) or Ullrich-Turner syndrome (n = 21). When expressed relative to body weight (Gal-Hyl/wt), urinary Gal-Hyl excretion was 3.2 to 4.7 times higher in subjects 4-16 yr of age than in adults. Highest values were observed in very young children and during the pubertal growth spurt. In the total population, urinary Gal-Hyl/wt was closely related to growth velocity (r = 0.72) and significantly correlated with the urinary excretion of both hydroxyproline (r = 0.74) and deoxypyridinoline (r = 0.88; P < 0.001 each). Urinary Gal-Hyl/wt was significantly lower in children with GH deficiency or Ullrich-Turner syndrome than in healthy children (P < 0.001 each). The urinary excretion of Gal-Hyl was significantly correlated with growth velocity in GH-deficient children (r = 0.69; P = 0.004) but not in patients with Ullrich-Turner syndrome. In the latter, the increase in urinary Gal-Hyl excretion after 3 months of treatment with recombinant human GH correlated significantly with the increase in growth velocity after 12 months of treatment (r = 0.76; P = 0.002). We conclude that the urinary excretion of Gal-Hyl is a valid and potentially useful index of skeletal growth in children.